Effects of teriparatide [rhPTH (1-34)] treatment on structural geometry of the proximal femur in elderly osteoporotic women.

@article{UusiRasi2005EffectsOT,
  title={Effects of teriparatide [rhPTH (1-34)] treatment on structural geometry of the proximal femur in elderly osteoporotic women.},
  author={Kirsti Uusi-Rasi and Lisa M. Semanick and Jose Rub{\'e}n Zanchetta and Cesar E. Bogado and Erik Fink Eriksen and Masahiko Sato and Thomas J. Beck},
  journal={Bone},
  year={2005},
  volume={36 6},
  pages={948-58}
}
INTRODUCTION We evaluated effects of teriparatide (rDNA origin) injection [teriparatide, rhPTH (1-34), TPTD] on hip structure among a subset 558 postmenopausal women enrolled in the Fracture Prevention Trial. METHODS Patients were randomized to once-daily, self-administered subcutaneous injections of placebo (N = 189), teriparatide 20 mug (TPTD20; N = 186), or 40 mug (TPTD40; N = 183) for a median of 20 months. Repeated dual energy X-ray absorptiometry (DXA) hip scans were analyzed with the… CONTINUE READING

Citations

Publications citing this paper.
Showing 1-10 of 49 extracted citations

Similar Papers

Loading similar papers…